Cryptococcosis complicating diabetes mellitus: a scoping review.

clinical characteristics cryptococcosis diabetes mellitus mortality

Journal

Therapeutic advances in infectious disease
ISSN: 2049-9361
Titre abrégé: Ther Adv Infect Dis
Pays: England
ID NLM: 101606715

Informations de publication

Date de publication:
Historique:
received: 19 12 2020
accepted: 13 04 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM. MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded. A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% ( A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM.

Sections du résumé

BACKGROUND BACKGROUND
A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to
OBJECTIVE OBJECTIVE
The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM.
METHODS METHODS
MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded.
RESULTS RESULTS
A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (
CONCLUSION CONCLUSIONS
A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM.

Identifiants

pubmed: 33996076
doi: 10.1177/20499361211014769
pii: 10.1177_20499361211014769
pmc: PMC8111545
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20499361211014769

Informations de copyright

© The Author(s), 2021.

Déclaration de conflit d'intérêts

Conflict of interest statement: The authors declare that there is no conflict of interest.

Références

Brain Pathol. 1998 Jan;8(1):235-6
pubmed: 9458181
J Thorac Imaging. 2005 May;20(2):115-7
pubmed: 15818212
BMC Infect Dis. 2019 Jan 3;19(1):5
pubmed: 30606110
J Infect Chemother. 2012 Oct;18(5):775-9
pubmed: 22318291
Mycopathologia. 2009 Mar;167(3):125-31
pubmed: 18931938
PLoS One. 2015 Aug 19;10(8):e0136280
pubmed: 26287949
J Leukoc Biol. 1994 Jan;55(1):35-42
pubmed: 7904293
Clin Infect Dis. 2010 Aug 15;51(4):448-55
pubmed: 20597693
Am J Hyg. 1955 Nov;62(3):227-32
pubmed: 13268414
Am J Orthop (Belle Mead NJ). 2015 Dec;44(12):E517-22
pubmed: 26665255
Tuberc Respir Dis (Seoul). 2015 Jul;78(3):276-80
pubmed: 26175785
J Infect. 2016 May;72(5):608-14
pubmed: 26920792
Enferm Infecc Microbiol Clin. 2014 Dec;32(10):643-6
pubmed: 24365474
Methods Mol Med. 2005;118:193-8
pubmed: 15888944
Nihon Ishinkin Gakkai Zasshi. 2009;50(2):95-9
pubmed: 19430184
Int J Infect Dis. 2006 Jan;10(1):72-8
pubmed: 16288998
J Microbiol Immunol Infect. 2011 Oct;44(5):338-45
pubmed: 21524972
Cutis. 2014 Aug;94(2):91-5
pubmed: 25184644
Proc Am Thorac Soc. 2010 May;7(3):186-96
pubmed: 20463247
Clin Infect Dis. 2001 Sep 1;33(5):690-9
pubmed: 11477526
Clin Infect Dis. 2010 Feb 1;50(3):291-322
pubmed: 20047480
Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):937-43
pubmed: 18449582
Medicine (Baltimore). 2004 May;83(3):188-192
pubmed: 15118545
QJM. 2000 Apr;93(4):245-51
pubmed: 10787453
Cold Spring Harb Perspect Med. 2014 Jul 01;4(7):a019760
pubmed: 24985132
Lancet Infect Dis. 2015 Mar;15(3):348-55
pubmed: 25467646
Diagn Cytopathol. 1991;7(4):415-6
pubmed: 1935520
Acta Neurol Belg. 2020 Oct;120(5):1139-1145
pubmed: 31321616
Mycoses. 2017 Nov;60(11):706-713
pubmed: 28857298
Curr Clin Microbiol Rep. 2017 Jun;4(2):88-95
pubmed: 29130027
Clin Infect Dis. 2020 Jan 2;70(2):252-261
pubmed: 30855688
Arch Intern Med. 1975 Sep;135(9):1155-7
pubmed: 1100006
BMC Geriatr. 2019 Mar 25;19(1):91
pubmed: 30909914
Rinsho Shinkeigaku. 2016;56(1):27-31
pubmed: 26616484
J Intern Med. 1991 Sep;230(3):285-7
pubmed: 1895053
Med Mycol Case Rep. 2020 Feb 24;28:1-3
pubmed: 32154097
J Family Med Prim Care. 2019 Mar;8(3):1253-1256
pubmed: 31041285
Acta Trop. 2020 Feb;202:105205
pubmed: 31580849
Nihon Kokyuki Gakkai Zasshi. 2004 Mar;42(3):272-6
pubmed: 15069786
J Clin Neurosci. 2018 Sep;55:57-61
pubmed: 30042070
Neurol India. 2003 Sep;51(3):364-6
pubmed: 14652440
Mycopathologia. 2012 Jul;174(1):81-5
pubmed: 22246960
J Immunol. 1950 May;64(5):423-30
pubmed: 15415610
J Int Med Res. 2020 Jun;48(6):300060520927877
pubmed: 32527202
Nat Rev Microbiol. 2016 Feb;14(2):106-17
pubmed: 26685750
Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):307-10
pubmed: 18157678
J Glob Infect Dis. 2017 Oct-Dec;9(4):157-159
pubmed: 29302151
BMC Infect Dis. 2020 May 20;20(Suppl 1):324
pubmed: 32429962
IDCases. 2020 Oct 24;22:e00988
pubmed: 33204630
Mycopathologia. 2016 Dec;181(11-12):899
pubmed: 27495123
Clin Infect Dis. 2018 Feb 1;66(4):608-611
pubmed: 29028978
Emerg Infect Dis. 2014 Jan;20(1):45-53
pubmed: 24378231
J Infect Chemother. 2015 Jan;21(1):23-30
pubmed: 25444673
J Diabetes Investig. 2020 May;11(3):731-744
pubmed: 31758642
Intern Med. 2014;53(12):1385-90
pubmed: 24930663
Trans Am Clin Climatol Assoc. 2013;124:61-79
pubmed: 23874010
Nihon Kokyuki Gakkai Zasshi. 2011 Feb;49(2):142-7
pubmed: 21400913

Auteurs

Lauryn Nsenga (L)

School of Medicine, Kabale University, Kabale, Uganda.

Jonathan Kajjimu (J)

Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

Ronald Olum (R)

Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Sandra Ninsiima (S)

Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Andrew Peter Kyazze (AP)

Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Phillip Ssekamatte (P)

Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.

Davis Kibirige (D)

Department of Medicine, Uganda Martyrs Lubaga Hospital, Kampala, Uganda.

Joseph Baruch Baluku (JB)

Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.

Irene Andia-Biraro (I)

Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Felix Bongomin (F)

Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, P.O. Box, 166, Gulu, Uganda.

Classifications MeSH